-
IUPAC Name:2-[3'-(benzyloxy)-3-nitro-[1,1'-biphenyl]-4-yl]acetic acidFor a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:3'-(benzyloxy)-4-fluoro-5-nitro-[1,1'-biphenyl]-3-carboxylic acidFor a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:N-(5-ethyl-8,9-dimethoxy-5,6-dihydrophenanthridin-4-yl)-2,2,2-trifluoroacetamide
Supplier Lead time Price, € Pack Targetmol Chemicals IncShips from: United StatesTo:30 days 1,520 Description: SARS-CoV-2-IN-17 (Compound 16) is a highly effective inhibitor of the SARS-CoV-2 nucleocapsid protein (NPro), demonstrating potent antiviral activity with an EC50 value of 2.18 μM and binding to NPro with a low Kd value of 7.82 μM, underscoring its potency as a NPro ligand [1].; CAS: 2761911-44-6MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: SARS-CoV-2-IN-17; Product Description: SARS-CoV-2-IN-17 (Compound 16) is a potent SARS-CoV-2 nucleocapsid protein ( NPro ) inhibitor. SARS-CoV-2-IN-17 exhibits potent anti-viral activity with the EC 50 of 2.18 μM. SARS-CoV-2-IN-17 binds to NPro with the low K D value of 7.82 μM, suggesting that SARS-CoV-2-IN-17 is a potent NPro ligand .; Target: SARS-CoV; CAS: 2761911-44-6MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: SARS-CoV-2-IN-17; Product Description: SARS-CoV-2-IN-17 (Compound 16) is a potent SARS-CoV-2 nucleocapsid protein (NPro) inhibitor. SARS-CoV-2-IN-17 exhibits potent anti-viral activity with the EC50 of 2.18 μM. SARS-CoV-2-IN-17 binds to NPro with the low KD value of 7.82 μM, suggesting that SARS-CoV-2-IN-17 is a potent NPro ligand; Target: SARS-CoV; CAS: 2761911-44-6For a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:1-[6-chloro-3'-(4-chlorophenoxy)-[1,1'-biphenyl]-3-yl]-2,5-dimethyl-1H-pyrroleFor a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:3-amino-4'-bromo-5-(3,4-dimethoxyphenyl)-[1,1'-biphenyl]-2,4-dicarbonitrile
Supplier Lead time Price, € Pack Key Organics Limited (BIONET)Ships from: United KingdomTo:TBD POA1 gFor a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:N-[2-chloro-3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-carboxamide
Supplier Lead time Price, € Pack Accela ChemBio Inc.Ships from: United StatesTo:10 days 196 Description: N-[2-Chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)phenyl]-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide; CAS: 2170210-17-8Advanced ChemBlock IncShips from: United StatesTo:30 days 290 Description: N-[2-Chloro-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)phenyl]-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide; CAS: 2170210-17-8For a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:N-[2-cyano-3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-carboxamide
Supplier Lead time Price, € Pack Targetmol Chemicals IncShips from: United StatesTo:30 days 1,520 Description: PD-1/PD-L1-IN 5 is a potent inhibitor of the PD-1/PD-L1 protein/protein interaction (IC50 ≤ 100 nM).; CAS: 2170209-51-3MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: PD-1/PD-L1-IN 5; Product Description: PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC 50 of ≤100 nM .; Target: PD-1/PD-L1; CAS: 2170209-51-3MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: PD-1/PD-L1-IN 5; Product Description: PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM; Target: PD-1/PD-L1; CAS: 2170209-51-3For a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:N-[2-cyano-3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-carboxamide; trifluoroacetic acid
Supplier Lead time Price, € Pack MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: PD-1/PD-L1-IN 5 (TFA); Product Description: PD-1/PD-L1-IN 5 TFA is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM; Target: PD-1/PD-L1; CAS: 2170209-52-4For a custom pack size or bulk
please drop us a line:Enquire -